Clinical Trial Update: Intratumoral Targeted Hyperthermia Therapy (THT) for Cutaneous Metastatic Melanoma [NA]

View source ↗

Summary

A clinical trial update for Intratumoral Targeted Hyperthermia Therapy (THT) in cutaneous metastatic melanoma, currently not yet recruiting and sponsored by Son…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Intratumoral Targeted Hyperthermia Therapy (THT)

Snippet

Sponsor: Sona Nanotech Inc | Conditions: Cutaneous Metastatic Melanoma | NA | Status: NOT_YET_RECRUITING